home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

p53 Hampers Energy Metabolism In Cancer Cells

  April, 17 2008 7:11
your information resource in human molecular genetics

The tumour suppressor p53 can limit tumour development by inhibiting aerobic glycolysis reports a paper published online in Nature Cell Biology.

Cancer cells normally shift their metabolism to aerobic glycolysis - the conversion of glucose to lactic acid in the presence of oxygen - which confers an advantage in sustaining tumour growth.

p53 activity is lost in over half of human tumours; its primary role is to eliminate cells that have undergone oncogenic transformation by inducing cell growth arrest or programmed cell death. Nobuyuki Tanaka and colleagues found, by looking at p53-deficient primary fibroblasts, that loss of p53 leads to higher glucose metabolism, and demonstrated that this requires de-repression of the transcription factor NF-kB and one of its target genes called GLUT3.

This work reveals an additional function of p53 in restricting cell proliferation through suppression of NF-kB, which is important for maintaining normal levels of glucose metabolism and cell growth.

Author contact:

Nobuyuki Tanaka (Nippon Medical School, Kawasaki-shi, Japan)
E-mail: nobuta@nms.ac.jp

Abstract available online.

(C) Nature Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.